Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API’s), Pharma Intermediates, Specialty Chemicals as well as Formulations.
Financial Results:
Aarti Drugs Ltd reported Revenues for Q1FY24 of ₹592.00 Crores up from ₹551.00 Crore year on year, a rise of 7.44%.
Total Expenses for Q1FY24 of ₹540.00 Crores up from ₹515.00 Crores year on year, a rise of 4.85%.
Consolidated Net Profit of ₹40.00 Crores up 53.85% from ₹26.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹4.27, up 49.82% from ₹2.85 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.